Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Issue of Equity

25 Aug 2016 14:00

RNS Number : 1613I
Tavistock Investments PLC
25 August 2016
 

Tavistock Investments Plc

Issue of Equity

25 August 2016

Tavistock Investments Plc ("Tavistock" or the "Company") the integrated financial services business, announces that Oliver Cooke, Chairman, and Brian Raven, Chief Executive, have today exercised their options to subscribe for G Ordinary Shares in the Company. Mr Cooke and Mr Raven each held options to subscribe for 50,000 G Ordinary Shares at a price of 1 penny per share which were granted to them under the Company's EMI Share Option Scheme as a performance incentive and the exercise of which was subject to the achievement of certain milestones, all of which been met.

The G Ordinary Shares, as a class, can be converted at any time between 1 August 2016 and 31 July 2018 at the request of the holders into such number of new ordinary shares of 1p each in the Company ("Ordinary Shares") as represents 10 per cent. of the fully diluted share capital of Tavistock as at 31 July 2016 as enlarged by such conversion. Mr Cooke and Mr Raven have notified the Company of their intention to convert, which is irrevocable. Upon conversion, each of Mr Cooke and Mr Raven will receive 22,927,017 Ordinary Shares and application will be made in due course for the aggregate 45,854,034 Ordinary Shares to be admitted to trading on AIM.

The interests of Mr Cooke and Mr Raven in the share capital of the Company before and after conversion of the G Ordinary Shares is set out below, assuming no other issues of equity:

As at the date of this announcement

Ordinary Shares

%

Options to subscribe for Ordinary Shares

G Ordinary Shares

Oliver Cooke

2,128,206

0.54%

1,600,000

50,000

Brian Raven

38,542,362

9.74%

1,600,000

50,000

 

Following conversion of G Ordinary Shares into Ordinary Shares

Ordinary Shares

%

Options to subscribe for Ordinary Shares

Oliver Cooke

25,055,223

5.67%

1,600,000

Brian Raven

61,469,379

13.92%

1,600,000

 

A further announcement regarding the issue of the Ordinary Shares arising upon the conversion of the G Ordinary Shares will be made in due course.

 

For further information:

 

Tavistock Investments plc Tel: 01753 867000

Oliver Cooke, Executive Chairman

Brian Raven, Group Chief Executive

 

Northland Capital Partners Limited Tel: 020 3861 6625

William Vandyk

Matthew Johnson

 

WH Ireland Limited Tel: 0113 394 6600

Tim Feather

Liam Gribben

 

Templars Communications Limited Tel: 020 3642 3140

Kitty Parry

Kate Boothman Meier

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFELFLQVFEBBD
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.